Default company panoramic image
3a2076e3 e4b1 4b4a 84aa f65919801868

EpitoGenesis Inc.

EpitoGenesis, Inc. is developing a novel nutritive, non-inflammatory, immune-boosting formulation to make safer and more effective vaccines.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Walnut Creek, CA, USA
  • Currency USD
  • Founded November 2008
  • Website epitogenesis.com

Company Summary

Current vaccines are based on induction of inflammatory immune responses. Our formulation (NIDS), is designed by a Mucosal Immunologist, contains two vitamins and a tea derivative in vegetable oil, is as effective as other vaccine formulations, and yet induces no local or systemic common vaccination-related side effects, like pain, rashes, itching, fever, etc. NIDS can also be taken orally as a general immune-booster by the elderly and infants.

Team

Advisors

  • Default avatar
    Alicia Russo with Fitzpatrick, Cella, Harper, Scinto IP Law Firm
    Lawyer
    Unconfirmed
    Default avatar
    Michael Sassi of M D Sassi Company in San Francisco
    Accountant
    Unconfirmed

Previous Investors

  • Default avatar
    none
    Unconfirmed